Her family kept getting cancer. At 33, a saliva test explained why

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-10-04T11:12:58.142Z • Permanent link

Michelle York's life was forever changed when her mother was diagnosed with cancer at the age of 32. The young woman's mother, who had no family history of the disease, underwent a series of tests that revealed she had Lynch syndrome, a rare genetic condition that significantly increases the risk of developing cancer. Determined to learn more about her own risk, York decided to get tested for the condition.

York's journey began in 2019 when she visited the National Cancer Institute's (NCI) website and learned about Lynch syndrome. The website provided information on the condition, including its symptoms and risk factors. York noticed that her mother's cancer diagnosis was eerily similar to those of her mother's relatives, but she couldn't pinpoint a clear family history. Undeterred, she decided to take matters into her own hands and schedule a consultation with a genetic counselor.

Under the guidance of the NCI's genetic counseling program, York underwent a saliva test that would reveal whether she carried the mutation responsible for Lynch syndrome. The test, which was developed by a team of researchers at the National Human Genome Research Institute (NHGRI), is designed to detect the presence of the BRCA2 and MLH1 genes, which are commonly associated with Lynch syndrome. York's results, which were received in June 2020, confirmed that she was indeed a carrier of the mutation, putting her at significantly increased risk of developing cancer.

The discovery of Lynch syndrome in Michelle York has significant implications for the Data Sources domain. For companies that specialize in genetic testing and counseling, the development of more accurate and accessible tests like York's saliva test is a major breakthrough. Companies such as Invitae and LabCorp, which offer genetic testing services, will need to reassess their offerings in light of this new technology. Furthermore, the increasing awareness of Lynch syndrome will likely lead to a surge in demand for genetic testing and counseling services, which will create new opportunities for research communities, markets, and policy environments.

The impact of this development will also be felt in the research community, where scientists will need to adapt their approaches to account for the growing awareness of Lynch syndrome. Researchers at institutions such as the NCI and the NHGRI will need to re-evaluate their data analysis and interpretation methods to ensure that they are capturing the full range of genetic variants associated with the condition. This will require significant investment in new technologies and methodologies, but it will ultimately lead to a deeper understanding of Lynch syndrome and its impact on individuals and families.

The discovery of Lynch syndrome in Michelle York is part of a larger pattern of innovation in the field of genetic testing and counseling. In recent years, there has been a significant increase in the development of new genetic tests and technologies, which have made it possible for individuals to take a more active role in their own health. The Human Genome Project, which was completed in 2003, paved the way for the development of genetic testing technologies, while initiatives such as the 100,000 Genomes Project have made it possible for individuals to access genetic testing services at a lower cost.